| Name | 5-(4-Methylpiperazin-1-yl)-1,3,4-thiadiazol-2-amine |
|---|---|
| Synonyms |
2-Amino-5-(4-methylpiperazino)-1,3,4-thiadiazol
5-((4-Methylphenyl)sulfonyl)-2-furancarbonitrile 5-(4-methylphenylsulfonyl)-2-furonitrile 5-<(4-methylphenyl)sulphonyl>-2-furancarbonitrile 5-(4-methyl-piperazin-1-yl)-[1,3,4]thiadiazol-2-ylamine 2-Furancarbonitrile,5-((4-methylphenyl)sulfonyl) 2-amino-5-(4-methyl-1-piperazinyl)-1,3,4-thiadiazole 5-(p-tolylsulphonyl)-2-cyanofuran |
| Molecular Formula | C7H13N5S |
|---|---|
| Molecular Weight | 199.27700 |
| Exact Mass | 199.08900 |
| PSA | 86.52000 |
| LogP | 0.45620 |
| HS Code | 2934999090 |
|---|
|
~%
71125-50-3 |
| Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2004/78754 A1, 2004 ; Location in patent: Page 50 ; WO 2004/078754 A1 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |